Proteomic changes in Bacteroides fragilis exposed to subinhibitory concentration of piperacillin/tazobactam. 2013

Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas, C4-204 Departamento de Microbiologia, Laboratório de Microbiologia Oral e Anaeróbios, Av. Antônio Carlos, 6627 Pampulha, CEP-31270-901 Belo Horizonte, Minas Gerais, Brazil. lucianocvbio@gmail.com

Bacteroides fragilis is the anaerobe most frequently isolated from clinical specimens and piperacillin/tazobactam is among the drugs that can be used to treat polymicrobial infections in which this bacteria is often involved. During antibiotic therapy, inhibitory concentrations of antibiotics are always followed by subinhibitory concentrations which can generate phenotypic changes in bacteria. So, in this study we aimed to evaluate changes in the proteomic profile of B. fragilis grown in a sub-MIC of PTZ, using 2-D electrophoresis followed by matrix-assisted laser desorption/ionization time-of-flight/time of-flight. Analysis of the 2-DE gels showed 18 spots with significantly different volume percentages between experimental conditions and 12 were successfully identified by MS/MS. Two proteins with decreased abundance in sub-MIC condition were involved in the glycolysis (glyceraldehyde-3-phosphate dehydrogenase and triose phosphate isomerase), others two involved in amino acid metabolism (Oxoacyl-(acyl-carrier protein) synthase II and dihydrodipicolinate reductase), and finally, one protein involved in fatty acid metabolism (UDP-N-acetylglucosamine acyltransferase). Among the proteins with increased abundance, we founded three ATP synthase (alpha, beta, and alpha type V), which could be involved in antibiotic bacterial resistance by efflux pump, one protein involved in glycolysis (enolase), and one involved in protein degradation (aminoacyl-histidine dipeptidase). In conclusion, our data show overall changes in the proteome of B. fragilis conducted by sub-MIC of PTZ, whose consequences on bacterial physiology deserve further investigation.

UI MeSH Term Description Entries
D010397 Penicillanic Acid A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed) Acid, Penicillanic
D010878 Piperacillin Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics. AB-Piperacillin,Cl-227193,Pipcil,Pipera-Hameln,Piperacillin Curasan,Piperacillin Fresenius,Piperacillin Hexal,Piperacillin Monosodium Salt,Piperacillin Sodium,Piperacillin-Ratiopharm,Pipercillin,Pipracil,Pipril,T-1220,T1220,AB Piperacillin,Cl 227193,Cl227193,Curasan, Piperacillin,Monosodium Salt, Piperacillin,Pipera Hameln,Piperacillin Ratiopharm,Salt, Piperacillin Monosodium,Sodium, Piperacillin,T 1220
D000077725 Piperacillin, Tazobactam Drug Combination An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity. It is also used for the treatment of PSEUDOMONAS AERUGINOSA INFECTIONS. Piperacillin - Tazobactam,Piperacillin-Tazobactam Combination Product,Pipercillin Sodium - Tazobactam Sodium,Pipercillin Sodium, Tazobactam Sodium Drug Combination,Tazocel,Tazocillin,Tazocin,Zosyn,Piperacillin Tazobactam,Piperacillin Tazobactam Combination Product,Pipercillin Sodium Tazobactam Sodium,Tazobactam, Piperacillin -
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001441 Bacteroides fragilis Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance
D040901 Proteomics The systematic study of the complete complement of proteins (PROTEOME) of organisms. Peptidomics

Related Publications

Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
January 1990, Chemotherapy,
Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
September 2004, Journal of medical microbiology,
Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
January 2016, Frontiers in microbiology,
Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
June 2007, Journal of medical microbiology,
Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
November 2007, Journal of medical microbiology,
Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
August 2010, Journal of chemotherapy (Florence, Italy),
Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
January 1989, Diagnostic microbiology and infectious disease,
Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
October 1994, The Journal of toxicological sciences,
Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
October 1994, The Journal of toxicological sciences,
Luciano de Castro Veloso, and Kênia Valéria dos Santos, and Hélida Monteiro de Andrade, and Simone da Fonseca Pires, and Simone Gonçalves dos Santos, and Mariana Jesus Vaz Trindade, and Luiz de Macêdo de Farias, and Maria Auxiliadora Roque de Carvalho
June 2012, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!